Oppenheimer & Co Inc’s Johnson & Johnson Position
Does Oppenheimer & Co Inc own Johnson & Johnson (JNJ)? Yes — 186.2K shares worth $46M (+0.55% of its 13F portfolio) as of Q1 2026, up from 177.9K shares the prior filed quarter.
Position Value
$46M
Q1 2026
Shares
186.2K
% of Portfolio
+0.55%
Quarters Held
30
currently held
Position History JNJ
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 186.2K | $46M | +0.55% |
| Q4 2025 | 177.9K | $37M | +0.52% |
| Q3 2025 | 183.4K | $34M | +0.41% |
| Q2 2025 | 182.1K | $28M | +0.37% |
| Q1 2025 | 177.8K | $29M | +0.45% |
| Q4 2024 | 181.5K | $26M | +0.39% |
| Q3 2024 | 179.7K | $29M | +0.44% |
| Q2 2024 | 179.6K | $26M | +0.42% |
| Q1 2024 | 179.1K | $28M | +0.47% |
| Q4 2023 | 191.0K | $30M | +0.55% |
| Q3 2023 | 198.5K | $31M | +0.64% |
| Q2 2023 | 231.0K | $38M | +0.77% |
| Q1 2023 | 242.7K | $38M | +0.80% |
| Q4 2022 | 236.8K | $42M | +0.95% |
| Q3 2022 | 300.4K | $49M | +1.15% |
| Q2 2022 | 295.9K | $53M | +1.13% |
| Q1 2022 | 296.9K | $53M | +0.95% |
| Q4 2021 | 288.1K | $49M | +0.86% |
| Q3 2021 | 292.0K | $47M | +0.88% |
| Q2 2021 | 292.9K | $48M | +0.86% |
| Q1 2021 | 290.0K | $48M | +0.95% |
| Q4 2020 | 292.4K | $46M | +0.97% |
| Q3 2020 | 278.8K | $42M | +1.04% |
| Q2 2020 | 288.1K | $41M | +1.05% |
| Q1 2020 | 278.4K | $37M | +1.11% |
| Q4 2019 | 235.3K | $34M | +0.85% |
| Q3 2019 | 218.0K | $28M | +0.77% |
| Q2 2019 | 220.9K | $31M | +0.84% |
| Q1 2019 | 246.5K | $34M | +0.92% |
| Q4 2018 | 241.9K | $31M | +0.98% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Oppenheimer & Co Inc’s full portfolio or all institutional holders of JNJ.